Cancer Therapeutics

Novel Human C3 Derivatives for Therapeutic Complement Depletion

RNA Sensor Platform for Targeting Cancer Fusion Genes and Transcripts

QSOX1 as an anti-neoplastic drug target

Brain Targeted Nanoparticles for Therapeutic Delivery

Targeted Therapy for Triple-Negative Breast Cancer

CRISPR Platform & Portfolio

CRISPR Platform & Portfolio

Creation of Multivalent Aptamers to Target Effector T Cells to Attack Tumor Cells

Tumor-Targeted Killing with Aptamer-Nucleic Acid Nanostructures

Compounds to Modulate Retinoid X Receptors